A matched-pair analysis comparing systematic prostate biopsy by conventional transrectal ultrasound-guidance versus software-based predefined 3D-guidance
Objective - To compare software-based three-dimensional-guided systematic prostate biopsy (3D-GSB) with conventional transrectal ultrasound-guided systematic biopsy (TGSB) regarding prostate cancer (PCa) detection rates (CDR). - Methods - In total, 956 patients (200 TGSB patients and 756 3D-GSB pati...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
July 2023
|
| In: |
Urology
Year: 2023, Volume: 177, Pages: 128-133 |
| ISSN: | 1527-9995 |
| DOI: | 10.1016/j.urology.2023.03.027 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.urology.2023.03.027 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S009042952300287X |
| Author Notes: | Fabian Derigs, Karl-Friedrich Kowalewski, Friedrich Otto Hartung, Frank Waldbillig, Manuel Neuberger, Jost von Hardenberg, and Niklas Westhoff |
| Summary: | Objective - To compare software-based three-dimensional-guided systematic prostate biopsy (3D-GSB) with conventional transrectal ultrasound-guided systematic biopsy (TGSB) regarding prostate cancer (PCa) detection rates (CDR). - Methods - In total, 956 patients (200 TGSB patients and 756 3D-GSB patients) without prior positive biopsies and with a prostate-specific antigen value ≤20 ng/ml were eligible for analysis. TGSB and 3D-GSB cases were matched in a 1:1 ratio using propensity score matching with age, prostate-specific antigen, prostate volume, previous biopsy status, and suspicious palpatory finding as confounders. 3D-GSB was conducted with the semi-robotic prostate fusion-biopsy system Artemis. For each patient in both groups, SB was conducted in a similar pattern with 12 cores. All cores in 3D-GSB were automatically planned and mapped on a 3D-model as well as on the real-time transrectal ultrasound imaging. Primary end points were the clinically significant (cs) and overall CDR. Secondary end point was the cancer-positive core rate. - Results - After matching, the csCDR was not significantly different between the 3D-GSB and the TGSB groups (33.3% vs 28.8%, P = .385). Overall CDR was significantly higher for 3D-GSB compared to TGSB (55.6% vs 39.9%, P = .002). 3D-GSB detected significantly more non-significant PCa than TGSB (22.2% vs 11.1%, P = .004). In patients with PCa, the number of cancer-positive SB cores was significantly higher by TGSB (42% vs 25%, P < .001). - Conclusion - 3D-GSB was associated with a higher CDR than TGSB. However, no significant difference was shown in detection of csPCa between both techniques. Therefore, currently, 3D-GSB does not appear to add value to conventional TGSB. |
|---|---|
| Item Description: | Online verfügbar: 3. April 2023, Artikelversion: 10. August 2023 Gesehen am 20.11.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1527-9995 |
| DOI: | 10.1016/j.urology.2023.03.027 |